ImageFIRST Announces New Linen Risk Assessment for Healthcare Providers

ImageFirst reports the Linen Risk Assessment offers a comprehensive analysis of a healthcare provider’s linen program.

It is designed to help a provider understand if their linen is compliant with infection prevention recommendations and regulations. If not, the resulting customized report will highlight potential areas the facility can improve on.

ImageFIRST is offering its Linen Risk Assessment to medical facilities in the U.S., regardless of whether they are currently an ImageFIRST customer.

With healthcare now placing a greater emphasis on infection ​prevention more than ever, medical providers are looking​ for ways to minimize the spread of COVID-19 and sanitize ​common points of infection – including linen. ​The Joint Commission, an organization dedicated to continuous improvement in healthcare, recommends conducting a risk assessment to identify actual and potential risks. ​

Hygienically clean laundry is crucial to minimize the spread ​of pathogens according to the Centers for Disease Control ​and Prevention (CDC), the Association of periOperative ​Registered Nurses (AORN) and the Healthcare Laundry ​Accreditation Council (HLAC). ​​However, not all laundering is effective at removing bacteria. ​

The CDC states that dry cleaning is ineffective in reducing bacteria and viruses on linens, and that microorganisms can survive home laundering. OSHA regulations even prohibit home laundering of personal protective apparel such as lab coats, isolation gowns and scrubs. The CDC specifies that detergents used for healthcare laundry should be registered by the U.S. Environmental Protection Agency (EPA) to ensure adequate cleaning. ​

ImageFIRST offers fully-managed linen and apparel rental and laundry programs with comprehensive infection prevention processes that exceed standards and a wash process that is effective against COVID-19. Their laundering processes meet or exceed OSHA, CDC, HLAC requirements, and comply with The Joint Commission requirements.

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.